HISTOGEN INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3511 USD | +0.03% |
|
+0.29% | +14.10% |
| Apr. 19 | Subchapter V Trustee Appointed Under Chapter 11 for Histogen Inc. | CI |
| Apr. 18 | Histogen Inc. Filed for Bankruptcy | CI |
Valuation
| Fiscal Period: December | 2020 | 2021 | 2022 |
|---|---|---|---|
| Capitalization 1 | 11.39 | 16.62 | 3.546 |
| Enterprise Value (EV) 1 | 10.15 | 2.7 | -3.932 |
| P/E ratio | -0.36 x | -0.85 x | -0.24 x |
| Yield | - | - | - |
| Capitalization / Revenue | 5.53 x | 16.1 x | 0.94 x |
| EV / Revenue | 4.93 x | 2.62 x | -1.04 x |
| EV / EBITDA | -0.87 x | -0.18 x | 0.37 x |
| EV / FCF | -1,505,029 x | -253,350 x | 671,466 x |
| FCF Yield | -0% | -0% | 0% |
| Price to Book | 1.45 x | 0.78 x | 0.25 x |
| Nbr of stocks (in thousands) | 752 | 2,498 | 4,272 |
| Reference price 2 | 15.16 | 6.654 | 0.8300 |
| Announcement Date | 3/11/21 | 3/10/22 | 3/9/23 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net sales 1 | 9.648 | 1.777 | 11.45 | 2.059 | 1.032 | 3.769 |
| EBITDA 1 | 3.124 | -5.491 | -3.173 | -11.62 | -15.36 | -10.5 |
| EBIT 1 | 2.955 | -5.641 | -3.318 | -11.71 | -15.46 | -10.64 |
| Operating Margin | 30.63% | -317.45% | -28.97% | -568.92% | -1,497.77% | -282.38% |
| Earnings before Tax (EBT) 1 | 1.875 | -6.162 | -3 | -18.82 | -15.01 | -10.64 |
| Net income 1 | 1.875 | -6.125 | -2.966 | -18.77 | -14.95 | -10.62 |
| Net margin | 19.43% | -344.68% | -25.89% | -911.56% | -1,448.64% | -281.8% |
| EPS 2 | 8.181 | -54.00 | -26.00 | -41.62 | -7.794 | -3.460 |
| Free Cash Flow | - | -3.67 | -2.568 | -6.746 | -10.66 | -5.856 |
| FCF margin | - | -206.52% | -22.42% | -327.65% | -1,032.84% | -155.39% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 2/7/20 | 2/7/20 | 3/30/20 | 3/11/21 | 3/10/22 | 3/9/23 |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 |
|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 0.005 | 0.591 | 0.005 | 3.755 | 0.005 | 0.005 | 0.004 | 0.005 | 0.005 |
| EBITDA | - | - | - | - | - | - | - | - | - |
| EBIT 1 | -4.193 | -3.857 | -3.134 | -0.683 | -3.394 | - | -2.968 | -3.474 | -2.088 |
| Operating Margin | -83,860% | -652.62% | -62,680% | -18.19% | -67,880% | - | -74,200% | -69,480% | -41,760% |
| Earnings before Tax (EBT) | - | - | - | - | - | - | - | - | - |
| Net income | - | - | - | - | - | - | - | - | - |
| Net margin | - | - | - | - | - | - | - | - | - |
| EPS | - | - | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - | - |
| Announcement Date | 8/11/21 | 11/10/21 | 3/10/22 | 5/12/22 | 8/11/22 | 11/10/22 | 3/9/23 | 5/11/23 | 8/10/23 |
1USD in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 5.07 | 2.99 | 1.92 | 1.24 | 13.9 | 7.48 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow | - | -3.67 | -2.57 | -6.75 | -10.7 | -5.86 |
| ROE (net income / shareholders' equity) | - | -574% | -211% | -453% | -111% | -63.4% |
| ROA (Net income/ Total Assets) | - | -50.3% | -53.9% | -81.6% | -45.7% | -28.7% |
| Assets 1 | - | 12.19 | 5.499 | 23.02 | 32.7 | 36.98 |
| Book Value Per Share 2 | -282.0 | -302.0 | -318.0 | 10.50 | 8.490 | 3.370 |
| Cash Flow per Share 2 | 79.90 | 26.40 | 17.70 | 9.000 | 7.480 | 2.830 |
| Capex 1 | 0.03 | 0.13 | 0.15 | 0.05 | 0.24 | 0.22 |
| Capex / Sales | 0.31% | 7.09% | 1.33% | 2.38% | 23.35% | 5.73% |
| Announcement Date | 2/7/20 | 2/7/20 | 3/30/20 | 3/11/21 | 3/10/22 | 3/9/23 |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +14.10% | 1.5M | |
| -2.63% | 103B | |
| +1.62% | 95.28B | |
| +1.46% | 22.15B | |
| -16.67% | 21.02B | |
| -8.58% | 18.15B | |
| -38.74% | 16.73B | |
| -13.21% | 16.05B | |
| +5.41% | 13.68B | |
| +33.57% | 12.17B |
- Stock Market
- Equities
- HSTO Stock
- Financials Histogen Inc.
